
Varitide 0.05mg Injection
Marketer
J B Chemicals and Pharmaceuticals Ltd
Salt Composition
Octreotide acetate (0.05mg)
Overview Varitide 0.05mg Injection
Octreotide 0.05mg Injection treats acromegaly, carcinoid tumors, and bleeding esophageal varices, also preventing post-pancreatic surgery complications. Administration is solely by a medical professional; self-injection is contraindicated. Dosage and frequency are determined by your physician. Consistent use maximizes therapeutic effect; discontinue only upon medical advice. Common side effects include diarrhea, abdominal pain, nausea, constipation, gas, and headache. Report persistent or worsening side effects. Prior to treatment, disclose any liver conditions and all other medications currently in use.
Primary Ingredients of Varitide 0.05mg Injection
No text was provided to rewrite.
Uses of Varitide 0.05mg Injection
Overgrowth of the extremities, carcinoid cancers, and bleeding in the esophageal veins
Major Benefits of Varitide 0.05mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Varitide 0.05mg Injection:
- Diarrhea
- Abdominal pain
- Nausea
- Constipation
- Flatulence
- Headache
- Increased glucose level in blood
- Injection site reaction
How to use Varitide 0.05mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Varitide 0.05mg Injection works:
Varitide 0.05mg Injection mimics the action of somatostatin, a naturally occurring human hormone regulator. By suppressing specific hormone activity, including growth hormone, it also reduces esophageal bleeding through vasoconstriction.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Varitide 0.05mg Injection may be unsafe; physician consultation is advised.
PregnancySAFE IF PRESCRIBED
The administration of Varitide 0.05mg Injection during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Varitide 0.05mg Injection while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingSAFE
Administering a 0.05mg Varitide injection typically does not impair driving ability.
KidneySAFE IF PRESCRIBED
Varitide 0.05mg Injection poses no safety concerns for individuals with renal impairment. No alteration in Varitide 0.05mg Injection dosage is necessary for this patient population.
LiverCAUTION
Individuals with hepatic impairment should exercise caution when using Varitide 0.05mg Injection. Dosage modification of Varitide 0.05mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Varitide 0.05mg Injection :
For Varitide 0.05mg Injection, administer the missed dose promptly upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the forgotten dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Varitide 0.05mg Injection
| Label | Value |
|---|---|
| Chemical Type | Somatostatin analogs |
| Developing Habits | No. |
| Treatment Category | Endocrine Signals |
| Actions | Somatostatin receptor ligands |
